RJA
PFE icon

Ross\Johnson & Associates’s Pfizer PFE Stock Holding History

Ross\Johnson & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.33K Sell
83
-5
-6% -$133 0.04% 66
2025
Q4 		$2.19K Buy
88
+2
+2% +$50 0.04% 70
2025
Q3 		$2.19K Hold
86
– – 0.04% 67
2025
Q2 		$2.08K Hold
86
– – 0.04% 65
2025
Q1 		$2.18K Buy
86
+6
+8% +$157 0.04% 159
2024
Q4 		$2.12K Buy
+80
New +$2.17K 0.05% 69

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Ross\Johnson & Associates's PFE Position: Q1 2026 in Review

Ross\Johnson & Associates reduced its Pfizer (PFE) stake by 5.7% in Q1 2026, selling an estimated $133 and leaving 83 shares worth $2.33K. The position accounts for 0.04% of the portfolio, ranked #66.

Ross\Johnson & Associates first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Ross\Johnson & Associates held 83 shares of Pfizer worth $2.33K as of Q1 2026.
  • Ross\Johnson & Associates sold 5 Pfizer shares in Q1 2026, an estimated $133.
  • Pfizer made up 0.04% of Ross\Johnson & Associates's portfolio in Q1 2026, its #66 holding.
  • Ross\Johnson & Associates first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.